Weigh in on Transparency at the FDA

Seize the opportunity to share your suggestions on how the FDA can improve its currently opaque “transparency policy.“ A second public meeting will be held November 3, 2009, from 9 a.m. to 3 p.m. in the National Transportation Safety Board Conference Center at 429 L’Enfant Plaza, SW, Washington, DC (https://secure3.convio.net/aahf/site/Advocacy?cmd=display&page=UserAction&id=431). The three discussion groups are:

Read More

Citing Steroids in Supplements, Congress Considers Tweaking Dietary Regulations

According to the New York Times, federal agents have recently raided several companies suspected of making bodybuilding products that illegally contain steroids and selling them as over-the-counter dietary supplements. On September 29, 2009, Sen. Arlen Specter, D-Pa., chair of the Senate sub-committee on Judiciary, Crime and Drugs, convened a hearing on the topic. The forum […]

Read More

The US and UK Insist Aspartame is Safe Despite Reports of Serious Side Effects

Aspartame, the controversial artificial sweetener that is broken down to methanol and formaldehyde, has prompted thousands of reports to the FDA about adverse reactions, including Dr. Russell Blalock’s 1994 book Excitotoxins. In some people, aspartame, which is found in over 4,000 consumer products, causes symptoms ranging from headaches to dizziness, vomiting, fatigue and diarrhea.

Read More

Knee-Repair Device Reveals Political Pressures at the FDA

There’s an old adage, “Any publicity is good publicity,” but the exposure of four New Jersey lawmakers on the front page of the New York Times was anything but good news for them.  The article reported that Menaflex, a medical device that reinforces damaged knee tissue, was approved only after the two senators and two […]

Read More

ANH-USA Sues FDA

ANH-USA has filed three lawsuits against the FDA in recent weeks. In each case, we have been joined as plaintiffs by dietary supplement formulators Durk Pearson and Sandy Shaw and the Coalition to End FDA and FTC Censorship. We are being represented by the law firm of Emord & Associates.

Read More

FDA Attacks Natural Thyroid Millions Depend On

We have learned that Time-Cap Labs, producer of a generic version of the brand name drug Armour, a natural and bioidentical thyroid replacement, has been ordered by the FDA to stop production. The FDA has decided to classify the company’s product, available for over a century, as an unapproved new drug.  Since the new drug […]

Read More